References
  • 1 Adams, L., Lawson, N., Maxted, K.J. & Symonds, R.P. (1992) The prevention of hair loss from chemotherapy by the use of cold‐air scalp‐cooling. European Journal of Cancer Care, 1(5), 1619. Cross Ref link
  • 2 Aiello‐Lawes, L. & Rutlidge, D.N. (2014) In: Polovich, M., Olsen, M., LeFebvre, K. (eds) Chemotherapy and Biotherapy Guidelines and Recommendations for Practice. Administration Considerations, 4th edn. Pittsburgh, PA: Oncology Nursing Society, p. 123.
  • 3 Aisner, J. (2007) Overview of the changing paradigm in cancer treatment: oral chemotherapy. American Journal of Health‐System Pharmacy, 64(9 Suppl 5), S4S7.
  • 4 Allwood, M.C., Wright, P. & Stanley, A. (eds) (2002) The Cytotoxics Handbook, 4th edn. Oxford: Radcliffe Medical Press.
  • 5 Anderson, J.E., Hunt, J.M. & Smith, I.E. (1981) Prevention of doxorubicin‐induced alopecia by scalp cooling in patients with advanced breast cancer. BMJ, 282(6262), 423424. Cross Ref link Pubmed link
  • 6 Antipuesto, D.J. (2010) Z Track Method. Nursing Crib. Available at: http://nursingcrib.com/nursing‐notes‐reviewer/fundamentals‐of‐nursing/z‐track‐method/ (Accessed: 1/4/2018)
  • 7 Barber, N.A. & Gant, A.K. (2011) Pulmonary toxicities from targeted therapies: a review. Targeted Oncology, 6(4), 235243. Cross Ref link Pubmed link
  • 8 Barefoot, J., Bletcher, C.S. & Emery, R. (2009) Keeping pace with oral chemotherapy. Oncology Issues, 24(3), 3639. Cross Ref link
  • 9 Batchelor, D. (2001) Hair and cancer chemotherapy: consequences and nursing care – a literature study. European Journal of Cancer Care, 10(3), 147163. Cross Ref link Pubmed link
  • 10 Bedell, C.H. (2003) A changing paradigm for cancer treatment: the advent of new oral chemotherapy agents. Clinical Journal of Oncology Nursing, 7(6 Suppl), 59. Cross Ref link Pubmed link
  • 11 Bernhardson, B., Tishelman, C. & Rutqvist, L.E. (2009) Taste and smell changes in patients receiving cancer chemotherapy: distress, impact on daily life and self care strategies. Cancer Nursing, 32(1), 4554. Cross Ref link Pubmed link
  • 12 Bertelli, G. (1995) Prevention and management of extravasation of cytotoxic drugs. Drug Safety, 12(4), 245255. Cross Ref link Pubmed link
  • 13 Betticher, D.C., Delmore, G., Breitenstein, U., et al. (2013) Efficacy and tolerability of 2 scalp cooling systems for the prevention of alopecia associated with docetaxel treatment. Supportive Care in Cancer, 21(9), 25652573. Cross Ref link Pubmed link
  • 14 Birner, A.M., Bedell, M.K., Avery, J.T. & Ernstoff, M.S. (2006) Program to support safe administration of oral chemotherapy. Journal of Oncology Practice, 2(1), 56. Cross Ref link Pubmed link
  • 15 Boehmke, M.M. & Dickerson, S.S. (2005) Symptom, symptom experiences, and symptom distress encountered by women with breast cancer undergoing current treatment modalities. Cancer Nursing, 28(5), 382389. Cross Ref link Pubmed link
  • 16 BOPA (2004) Position statement on safe practice and the pharmaceutical care of patients receiving oral anticancer chemotherapy, in British National Formulary. London: Pharmaceutical Press.
  • 17 BOPA (2015) Standards for Reducing Risks Associated with e‐Prescribing Systems for chemotherapy. British Oncology Pharmacy Association. Available at: http://www.bopawebsite.org/sites/default/files/publications/Standards_reducing_risks_associated_ePrescribing_systems_chemo2015.pdf (Accessed: 7/5/2018)
  • 18 Botchkarev, V.A., Komarova, E.A., Siebenhaar, F. et al. (2000) p53 is essential for chemotherapy‐induced hair loss. Cancer Research, 60(18), 50025006. Pubmed link
  • 19 Boulanger, J., Ducharme, A., Dufour, A., Fortier, S., Almanric, K.; Comité de l’évolution de la pratique des soins pharmaceutiques (CEPSP); Comité de l’évolution des pratiques en oncologie (CEPO) (2015) Management of the extravasation of anti‐neoplastic agents. Supportive Care in Cancer, 23(5), 14591471. Cross Ref link Pubmed link
  • 20 Breed, W.P. (2004) What is wrong with the 30‐year‐old practice of scalp cooling for the prevention of chemotherapy‐induced hair loss? Supportive Care in Cancer, 12 (1), 35. Cross Ref link Pubmed link
  • 21 British Journal of Nursing (BJN) (2016) Be compliant, protect each other and stay safe: avoiding accidental exposure to cytotoxic drugs. British Journal of Nursing, 24(16), S156.
  • 22 Browall, M., Gaston‐Johansson, F. & Danielson, E. (2006) Post‐menopausal women with breast cancer: their experiences of the chemotherapy treatment period. Cancer Nursing, 29(1), 3442. Cross Ref link Pubmed link
  • 23 Bulow, J., Friberg, L., Gaardsting, O. & Hansen, M. (1985) Frontal subcutaneous blood flow, and epi‐ and subcutaneous temperatures during scalp cooling in normal man. Scandinavian Journal of Clinical and Laboratory Investigation, 45(6), 505508. Cross Ref link Pubmed link
  • 24 Campbell, K. (2005) Blood cells. Part three–granulocytes and monocytes. Nursing Times, 101(42), 2627.
  • 25 Camp‐Sorrell, D. (1998) Developing extravasation protocols and monitoring outcomes. Journal of Intravenous Nursing, 21(4), 232239. Pubmed link
  • 26 Camp‐Sorrell, D. (2005) Oncology Nursing Society Access Device Guidelines: Recommendations for Nursing Practice and Education. Pittsburgh, PA: Oncology Nursing Society.
  • 27 Camp‐Sorrell, D. (2018) In: Yarbro, C.H., Wujcik, D., Holmes Gobel, B. (eds) Cancer Nursing. Principles and Practice, 8th edn. Burlington, MA: Jones & Bartlett Learning, Chapter 16, p. 515.
  • 28 Carr, K. (1998) How I survived the fall out. You Magazine, Mail on Sunday, 10 May, pp. 6167.
  • 29 Chernecky, C., Butler, S.W., Graham, P. & Infortuna, H. (2002) Drug Calculations and Drug Administration. Philadelphia: W.B. Saunders.
  • 30 Choi, E.K., Kim, I.R., Chang, O., et al. (2014) Impact of chemotherapy induced alopecia distress on body image, psychosocial well‐being, and depression in breast cancer patients. Psychooncology, 23(10), 11031110. Cross Ref link Pubmed link
  • 31 Christodoulou, C., Klouvas, G., Efstathiou, E., et al. (2002) Effectiveness of the MSC cold cap system in the prevention of chemotherapy‐induced alopecia. Oncology, 62(2), 97102. Cross Ref link Pubmed link
  • 32 Chung, S., Low, S.K., Zembutsu, H., et al. (2013) A genome‐wide association study of chemotherapy‐induced alopecia in breast cancer patients. Pyschooncology in breast cancer patients. Breast Cancer Res, 15(5), R81. Cross Ref link Pubmed link
  • 33 Cigler, T., Isseroff, D., Fiederlein, B., et al. (2015) Efficacy of scalp cooling in preventing chemotherapy induced alopecia in breast cancer patients receiving adjuvant doctaxel and cyclophosphamide chemotherapy. Clinical Breast Cancer, 15(5), 332–334. Cross Ref link Pubmed link
  • 34 Cline, B.W. (1984) Prevention of chemotherapy‐induced alopecia: a review of the literature. Cancer Nursing, 7(3), 221228. Cross Ref link Pubmed link
  • 35 Comerford, K., Eggenberger, T. & Robinson, K. (2002) Chemotherapy infusions. In: Intravenous Therapy Made Incredibly Easy. Philadelphia: Springhouse Publishing.
  • 36 CP Pharmaceuticals (1999) How Quickly Could you Act? Wrexham: CP Pharmaceuticals.
  • 37 Crowe, M., Kendrick, M. & Woods, S. (1998) Is scalp cooling a procedure that should be offered to patients receiving alopecia induced chemotherapy for solid tumours? Proceedings of the 10th International Conference on Cancer Nursing, Jerusalem.
  • 38 Daanen, H.A., Peerbooms, M., van den Hurk, C.J., et al. (2015) Core temperature affects scalp skin temperature during scalp cooling. Journal of Dermatology, 54(8), 916921.
  • 39 David, J. & Speechley, V. (1987) Scalp cooling to prevent alopecia. Nursing Times, 83(32), 3637. Pubmed link
  • 40 Davis, S.T., Benson, B.G., Bramson, H.N., et al. (2001) Prevention of chemotherapy‐induced alopecia in rats by CDK inhibitors. Science, 291(5501), 134137. Cross Ref link Pubmed link
  • 41 Dean, J.C., Salmon, S.E. & Griffith, K.S. (1979) Prevention of doxorubicin‐induced hair loss with scalp hypothermia. New England Journal of Medicine, 301(26), 14271429. Cross Ref link Pubmed link
  • 42 Dean, J.C., Griffith, K.S., Cetas, T.C., et al. (1983) Scalp hypothermia: a comparison of ice packs and the Kold Kap in the prevention of doxorubicin‐induced alopecia. Journal of Clinical Oncology, 1(1), 3337. Cross Ref link Pubmed link
  • 43 DH (2000) An Organisation with a Memory. London: Department of Health. Available at: http://webarchive.nationalarchives.gov.uk/20130105144251/http://www.dh.gov.uk/prod_consum_dh/groups/dh_digitalassets/@dh/@en/documents/digitalasset/dh_4065086.pdf (Accessed: 8/5/2018)
  • 44 DH (2003) Building a Safer NHS for Patients: Improving Medication Safety. London: Department of Health.
  • 45 DH (2005) Hazardous Waste (England) Regulations. London: Department of Health.
  • 46 DH (2007) Cancer Reform Strategy. London: Department of Health. Available at: https://www.nhs.uk/NHSEngland/NSF/Documents/Cancer%20Reform%20Strategy.pdf (Accessed: 8/5/2018)
  • 47 DH (2008) Updated national guidance on the safe administration of intrathecal chemotherapy. Available at: http://webarchive.nationalarchives.gov.uk/20121003015138/http://www.dh.gov.uk/en/Publicationsandstatistics/Lettersandcirculars/Healthservicecirculars/DH_086870 (Accessed: 8/5/2018)
  • 48 DH (2009a) Reference Guide to Consent for Examination or Treatment, 2nd edn. London: Department of Health. Available at: https://www.gov.uk/government/publications/reference‐guide‐to‐consent‐for‐examination‐or‐treatment‐second‐edition (Accessed: 1/4/2018)
  • 49 DH (2009b) The Operating Framework Enabling High Quality Care Throughout the NHS. London: Department of Health.
  • 50 DH (2013) Safe management of healthcare waste. Health Technical Memorandum. HTM 07.01 Available at: https://www.gov.uk/government/publications/guidance‐on‐the‐safe‐management‐of‐healthcare‐waste (Accessed: 7/5/2018)
  • 51 Dionyssiou, D., Chantes, A., Gravvanis, A., et al. (2011) The wash‐out technique in the management of delayed presentations of extravasation injuries. Journal of Hand Surgery, 36(1), 6669. Cross Ref link Pubmed link
  • 52 Doellman, D., Hadaway, L., Bowe‐Geddes, L.A., et al. (2009) Infiltration and extravasation: update on prevention and management. Journal of Infusion Nursing, 32(4), 203211. Cross Ref link Pubmed link
  • 53 Doroshow, J.H. (2012) Dexrazoxane for the prevention of cardiac toxicity and treatment of extravasation injury from the anthracycline antibiotics. Current Pharmaceutical Biotechnology, 13(10), 19491956. Cross Ref link Pubmed link
  • 54 Dougherty, L. (1996) Scalp cooling to prevent hair loss in chemotherapy. Professional Nurse, 11(8), 507509.
  • 55 Dougherty, L. (2003) The expert witness: working within the legal system of the United Kingdom. Journal of Vascular Access Devices, 8(2), 2935. Cross Ref link
  • 56 Dougherty, L. (2005) Alopecia. In: Brighton, D. & Wood, M. (eds) The Royal Marsden Hospital Handbook of Cancer Chemotherapy: A Guide for the Multidisciplinary Team. Edinburgh: Elsevier Churchill Livingstone, pp. 197200.
  • 57 Dougherty, L. (2006a) Central Venous Access Devices: Care and Management. Oxford: Blackwell Publishing.
  • 58 Dougherty, L. (2006b) Comparing methods to prevent chemotherapy‐induced alopecia. Cancer Nursing Practice, 5(6), 2531. Cross Ref link
  • 59 Dougherty, L. (2008a) IV therapy: recognizing the differences between infiltration and extravasation. British Journal of Nursing, 17(14), 896, 898901. Cross Ref link
  • 60 Dougherty, L. (2008b) Obtaining peripheral access. In: Dougherty, L. & Lamb, J. (eds) Intravenous Therapy in Nursing Practice, 2nd edn. Oxford: Blackwell Publishing.
  • 61 Dougherty, L. & Bailey, C. (2008) Chemotherapy. In: Corner, J. & Bailey, C. (eds) Cancer Nursing Care in Context. Oxford: Wiley‐Blackwell.
  • 62 Dougherty, L. & Lister, S. (eds) (2011) The Royal Marsden Hospital Manual of Clinical Nursing Procedures, 8th edn. Oxford: Wiley‐Blackwell.
  • 63 Dougherty, L. & Lister, S. (eds) (2015) The Royal Marsden Hospital Manual of Clinical Nursing Procedures, 9th edn. Oxford: Wiley‐Blackwell.
  • 64 Dougherty, L. & Oakley, C. (2011) Advanced practice in the management of extravasation. Cancer Nursing Practice, 10(5), 1618. Cross Ref link
  • 65 Downie, G., MacKenzie, J. & Williams, A. (2003) Medicine management. In: Downie, G., Mackenzie, J. & Williams, A. (eds) Pharmacology and Medicines Management for Nurses, 3rd edn. London: Churchill Livingstone, pp.4991.
  • 66 Dranitsaris, G., Johnston, M., Poirier, S. et al. (2005) Are health care providers who work with cancer drugs at an increased risk for toxic events? A systematic review and meta‐analysis of the literature. Journal of Oncology Pharmacy Practice, 11(2), 6978. Cross Ref link Pubmed link
  • 67 Eggert, J.A. (2018) Biology of cancer. In: Yarbro, C.H., Wujcik, D., Holmes Gobel, B. (eds) Cancer Nursing. Principles and Practice, 8th edn. Burlington, MA: Jones & Bartlett Learning.
  • 68 Ekwall, E.M., Nygren, L.M., Gustafsson, A.O. & Sorbe, B.G. (2013) Determination of the most effective cooling temperature for the prevention of chemotherapy‐induced alopecia. Molecular and Clinical Oncology, 1(6), 10651071. Cross Ref link Pubmed link
  • 69 Elkin, M.K., Perry, A.G. & Potter, P.A. (2007) Nursing Interventions and Clinical Skills, 4th edn. St Louis, MO: Mosby.
  • 70 El‐Saghir, N., Otrock, Z., Mufarrij, A., et al. (2004) Dexrazoxane for anthracycline extravasation and GM‐CSF for skin ulceration and wound healing. Lancet Oncology, 5(5), 320321. Cross Ref link Pubmed link
  • 71 EU (2010) Directive 2010/32/EUPrevention from Sharp Injuries in the Hospital and Healthcare Sector. Available at: www.osha.europa.eu/en/legislation/directives/sector‐specific‐and‐worker‐related‐provisions/osh‐directives/council‐directive‐2010‐32‐eu‐prevention‐from‐sharps‐injuries‐in‐the‐hospital‐and‐healthcare‐sector (Accessed: 1/4/2018)
  • 72 European Oncology Nursing Society (2007) Extravasation Guidelines: Guidelines Implementation Toolkit. Brussels: European Oncology Nursing Society.
  • 73 European Policy Recommendations (2016) Preventing occupational exposure to cytotoxic and other hazardous drugs. Available at: www.europeanbiosafetynetwork.eu (Accessed: 1/4/2018)
  • 74 Ferguson, L. & Wright, P. (2002) Health and safety aspects of cytotoxics services. In: Allwood, M. & Stanley, A. (eds) The Cytotoxics Handbook, 4th edn. Oxford: Radcliffe Medical Press, pp. 3562.
  • 75 Few, B.J. (1987) Hyaluronidase for treating intravenous extravasations. MCN: The American Journal of Maternal Child Nursing, 12(1), 2324. Cross Ref link Pubmed link
  • 76 Findlay, M., von Minckwitz, G. & Wardley, A. (2008) Effective oral chemotherapy for breast cancer: pillars of strength. Annals of Oncology, 19(2), 212222. Cross Ref link Pubmed link
  • 77 Fraise, A.P. & Bradley, T. (eds) (2009) Ayliffe's Control of Healthcare‐associated Infection: A Practical Handbook, 5th edn. London: Hodder Arnold.
  • 78 Freedman, T.G. (1994) Social and cultural dimensions of hair loss in women treated for breast cancer. Cancer Nursing, 17(4), 334341. Cross Ref link Pubmed link
  • 79 Friese, C.R., McArdle, C., Zhau, T., et al. (2015) Antineoplastic drug exposure in an ambulatory setting: a pilot study. Cancer Nurse, 38(2), 111117. Cross Ref link
  • 80 Gabriel, J. (2008) Safe administration of intravenous cytotoxic drugs. In: Dougherty L. & Lamb J. (eds) Intravenous Therapy in Nursing Practice, 2nd edn. Oxford: Blackwell Publishing, pp. 461494.
  • 81 Gallagher, J. (1996) Women's experiences of hair loss associated with chemotherapy – longitudinal perspective. Ninth International Conference on Cancer Nursing, Brighton.
  • 82 Gault, D. (1993) Extravasation injuries. British Journal of Plastic Surgery, 46(2), 9196. Cross Ref link Pubmed link
  • 83 Gault, D. & Challands, J. (1997) Extravasation of drugs. Anaesthesia Review, 13, 223241.
  • 84 Giaccone, G., Di Giulio, F., Morandini, M.P. & Calciati, A. (1988) Scalp hypothermia in the prevention of doxorubicin‐induced hair loss. Cancer Nursing, 11(3), 170173. Pubmed link
  • 85 Gilani, S. & Giridharan, S. (2014) Is it safe for pregnant health‐care professionals to handle cytotoxic drugs? A review of the literature and recommendations. ecancermedicalscience 8, 418. Cross Ref link Pubmed link
  • 86 Gonzalez, T. (2013) Chemotherapy extravasations: prevention, identification, management, and documentation. Clinical Journal of Oncology Nursing, 17(1), 6166. Cross Ref link Pubmed link
  • 87 Goodin, S. (2007) Safe Handling of Oral Chemo Agents in Community Settings. https://www.pharmacytimes.com/publications/issue/2007/2007‐09/2007‐09‐6789.
  • 88 Goolsby, T.V. & Lombardo F.A. (2006) Extravasation of chemotherapeutic agents: prevention and treatment. Seminars in Oncology, 33(1), 139143. Cross Ref link Pubmed link
  • 89 Gregory, R.P., Cooke, T., Middleton, J., et al. (1982) Prevention of doxorubicin‐induced alopecia by scalp hypothermia: relation to degree of cooling. BMJ, 284(6330), 1674. Cross Ref link Pubmed link
  • 90 Grevelman, E.G. & Breed, W.P. (2005) Prevention of chemotherapy‐induced hair loss by scalp cooling. Annals of Oncology, 16(3), 352358. Cross Ref link Pubmed link
  • 91 Griffith, R., Griffiths, H. & Jordan, S. (2003) Administration of medicines. Part 1: The law and nursing. Nursing Standard, 18(2), 4753. Cross Ref link Pubmed link
  • 92 Guy, R., Shah, S., Parker, H. & Geddes, D. (1982) Scalp cooling by thermocirculator. Lancet, 1(8278), 937938. Cross Ref link Pubmed link
  • 93 Hallam, C., Weston, V., Denton, A., et al. (2016) Development of the UK Vessel Health and Preservation (VHP) framework: a multi‐organisational collaborative. Journal of Infection Prevention, 17(2), 6572. Cross Ref link Pubmed link
  • 94 Hartigan, K. (2003) Patient education: the cornerstone of successful oral chemotherapy treatment. Clinical Journal of Oncology Nursing, 7(6 Suppl), 2124. Cross Ref link Pubmed link
  • 95 Haslam, I.S., Pitre, A., Schuetz, J.D. & Paus, R. (2013) Protection against chemotherapy‐induced alopecia: targeting ATP binding cassette transporters in the hair follicle? Trends in Pharmacological Sciences, 34(11), 599604. Cross Ref link Pubmed link
  • 96 Henricksen, T. & Jensen, B.K. (2003) Advanced computerised cold cap for preventing chemotherapy induced alopecia. Paper presented at ECCO, Copenhagen, 21–25th September.
  • 97 Hesketh, P.J., Batchelor, D., Golant, M., et al. (2004) Chemotherapy‐induced alopecia: psychosocial impact and therapeutic approaches. Supportive Care in Cancer, 12(8), 543549. Pubmed link
  • 98 Hidalgo, M., Rinaldi, D., Medina, G., et al. (1999) A phase I trial of topical topitriol (calcitriol, 1,25‐dihydroxyvitamin D3) to prevent chemotherapy‐induced alopecia. Anti‐Cancer Drugs, 10(4), 393395.
  • 99 Hilton, S., Hunt, K., Emslie, C., et al. (2008) Have men been overlooked? A comparison of young men and women's experiences of chemotherapy‐induced alopecia. Psychooncology, 17(6), 577583. Cross Ref link Pubmed link
  • 100 HM Government (2002) The Control of Substances Hazardous to Health Regulations 2002. London: Stationery Office. Available at: http://www.legislation.gov.uk/uksi/2002/2677/contents/made (Accessed: 7/5/2018)
  • 101 Holmberg, M. & Zanni, G.R. (2005) Bring hope home with oral antineoplastic agents. Pharmacy Times, 71(3), 103111.
  • 102 How, C. & Brown, J. (1998) Extravasation of cytotoxic chemotherapy from peripheral veins. European Journal of Oncology Nursing, 2(1), 5159. Cross Ref link
  • 103 Howard, N. & Stenner, R.W. (1983) An improved “ice‐cap” to prevent alopecia caused by adriamycin (doxorubicin). British Journal of Radiology, 56(672), 963964. Cross Ref link Pubmed link
  • 104 HSE (2017) Safe handling of cytotoxic drugs in the workplace. Available at: www.hse.gov.uk/healthservices/safe‐use‐cytotoxic‐drugs.htm (Accessed: 1/4/2018)
  • 105 HSE (2018) Latex allergies in health and social care. Available at: http://www.hse.gov.uk/healthservices/latex/ (Accessed: 7/5/2018)
  • 106 Huber, C. & Augustine, A. (2009) IV infusion alarms: don't wait for the beep. American Journal of Nursing, 109(4), 3233. Cross Ref link Pubmed link
  • 107 Hunt, J.M., Anderson, J.E. & Smith, I.E. (1982) Scalp hypothermia to prevent adriamycin‐induced hair loss. Cancer Nursing, 5(1), 2531. Pubmed link
  • 108 Hunter, J. (2008) Intramuscular injection techniques. Art and Science, 22(24), 3540.
  • 109 ICH (1996) ICH Harmonised Tripartite Guideline. Guideline For Good Clinical Practice E6(R1). Step 4. Available at: https://www.ich.org/fileadmin/Public_Web_Site/ICH_Products/Guidelines/Efficacy/E6/E6_R1_Guideline.pdf (Accessed: 1/4/2018)
  • 110 Ignoffo, R.J. & Friedman, M.A. (1980) Therapy of local toxicities caused by extravasation of cancer chemotherapeutic drugs. Cancer Treatment Reviews, 7(1), 1727. Cross Ref link Pubmed link
  • 111 Infusion Nurses Society (INS) (2006) Infusion nursing standards of practice. Journal of Infusion Nursing, 29(1), Suppl, S1S92. Cross Ref link Pubmed link
  • 112 Infusion Nurses Society (INS) (2016) Infusion Therapy Standards of Practice. Journal of Infusion Nursing, 39(1S), S1159.
  • 113 Institute for Safe Medication Practices (ISMP) (2007) The five rights: A Destination Without A Map. ISMP Medication Safety Alert Jan 25 2007. Institute for Safe Medication Practices. Available at: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2957754/pdf/ptj35_10p542.pdf (Accessed: 8/5/2018)
  • 114 Jackson, G. (2006) Consensus Opinion on the Use of Dexrazoxane (Savene) in the Treatment of Anthracycline Extravasation. UK: Topotarget.
  • 115 Jackson, T., Hallam, C., Corner, T. & Hill, S. (2013) Vascular access – right line, right patient, right time every choice matters. British Journal of Nursing, 22(8), S24S27. Cross Ref link Pubmed link
  • 116 Janssen, F.P.E.M. (2007) Modelling physiological and biochemical aspects of scalp cooling. Unpublished thesis.
  • 117 Kargar, M., Sarvestani, R.S., Khojasteh, H.N. & Heidari, M.T. (2011) Efficacy of penguin cap as scalp cooling system for prevention of alopecia in patients undergoing chemotherapy. Journal of Advanced Nursing, 67(11), 24732477. Cross Ref link Pubmed link
  • 118 Kassner, E. (2000) Evaluation and treatment of chemotherapy extravasation injuries. Journal of Pediatric Oncology Nursing, 17(3), 135148. Cross Ref link Pubmed link
  • 119 Katsimbri, P., Bamias, A. & Pavlidis, N. (2000) Prevention of chemotherapy‐induced alopecia using an effective scalp cooling system. European Journal of Cancer, 36(6), 766771. Cross Ref link Pubmed link
  • 120 Kav, S., Johnson, J., Rittenberg, C., et al. (2008) Role of the nurse in patient education and follow‐up of people receiving oral chemotherapy treatment: an international survey. Supportive Care in Cancer, 16(9), 10751083. Cross Ref link Pubmed link
  • 121 Kelland, L. (2005) Cancer cell biology, drug action and resistance. In: Brighton, D. & Wood, M. (eds) The Royal Marsden Hospital Handbook of Cancer Chemotherapy: A Guide for the Multidisciplinary Team. Edinburgh: Elsevier Churchill Livingstone, pp.315.
  • 122 Keller, J.F. & Blausey, L.A. (1988) Nursing issues and management in chemotherapy‐induced alopecia. Oncology Nursing Forum, 15(5), 603607. Pubmed link
  • 123 Kendell, P. (2001) Magic gel that helps cancer patients hold onto their hair. Daily Mail, 6 January, p. 19.
  • 124 Kennedy, M., Packard, R., Grant, M. et al. (1983) The effects of using Chemocap on occurrence of chemotherapy‐induced alopecia. Oncology Nursing Forum, 10(1), 1924. Pubmed link
  • 125 Khalili, M., Liao, C.E., & Nguten, T. (2009) Liver disease. In: Hammer, G.D. & McPhee, S.J. (eds) Pathophysiology of Disease: An Introduction to Clinical Medicine. New York: Lange Medical Books/McGraw‐Hill.
  • 126 Khan, M.S. & Holmes, J.D. (2002) Reducing the morbidity from extravasation injuries. Annals of Plastic Surgery, 48(6), 628632; discussion 632. Cross Ref link Pubmed link
  • 127 Komen, M.M., Smorenburg, C.H., van den Hurk, C.J. & Nortier, J.W. (2013) Factors influencing the effectiveness of scalp cooling in the prevention of chemotherapy induced alopecia. Oncologist, 18(7), 885891. Cross Ref link Pubmed link
  • 128 Langer, S. (2008) Treatment of anthracycline extravasation from centrally inserted venous catheters. Oncology Reviews, 2(2), 114116. Cross Ref link
  • 129 Langer, S.W., Sehested, M. & Jensen, P.B. (2000) Treatment of anthracycline extravasation with dexrazoxane. Clinical Cancer Research, 6(9), 36803686. Pubmed link
  • 130 Langer, S.W., Thougaard, A.V., Sehested, M. & Jensen, P.B. (2006) Treatment of anthracycline extravasation in mice with dexrazoxane with or without DMSO and hydrocortisone. Cancer Chemotherapy and Pharmacology, 57(1), 125128. Cross Ref link Pubmed link
  • 131 Lavery, I. & Ingram, P. (2006) Prevention of infection in peripheral intravenous devices. Nursing Standard, 20(49), 4956. Cross Ref link Pubmed link
  • 132 Lawson, T. (2003) A legal perspective on CVC‐related extravasation. Journal of Vascular Access Devices, 8(1), 2527. Cross Ref link
  • 133 Lemenager, M. (1998) Alopecia induced by chemotherapy – a controllable side‐effect. Oncology Nursing Today, 3(2), 1820.
  • 134 Lemenager, M., Genouville, C., Bessa, E.H. & Bonneterre, J. (1995) Docetaxel‐induced alopecia can be prevented. Lancet, 346(8971), 371372. Cross Ref link Pubmed link
  • 135 Lemenager, M., Lecomte, S., Bonneterre, M.E. et al. (1997) Effectiveness of cold cap in the prevention of docetaxel‐induced alopecia. European Journal of Cancer, 33(2), 297300. Cross Ref link Pubmed link
  • 136 Lemieux, J., Maunsell, E. & Provencher, L. (2008) Chemotherapy‐induced alopecia and effects on quality of life among women with breast cancer: a literature review. Psychooncology, 17(4), 317328. Cross Ref link Pubmed link
  • 137 Lemieux, J., Provencher, L., Perron, L., et al. (2015) No effect of scalp cooling on survival among women with breast cancer. Breast Cancer Research and Treatment, 149(1), 263268. Cross Ref link Pubmed link
  • 138 London Cancer Alliance (LCA) (2014a) Systemic Anti Cancer Treatment, Safe Handling and Drug Treatment. Knowledge and Skills Workbook 2014. Available at: http://www.londoncanceralliance.nhs.uk/media/95620/lca_sact_workbook_june_2014.pdf (Accessed: 7/5/2018)
  • 139 London Cancer Alliance (LCA) (2014b) Guidelines for the Use of Methylene Blue for the Treatment and Prophylaxis of Ifosfamide‐Induced Encephalitis. Available at: http://www.londoncancer.org/media/75878/London‐Cancer‐Methylene‐Blue‐Guideline‐v1.pdf (Accessed: 1/4/2018)
  • 140 London Cancer Alliance (LCA) (2015a) Pan London Guidelines for the Safe Prescribing, Handling and Administration of Systemic Anti‐Cancer Treatment Drugs. https://www.pharmacytimes.com/publications/issue/2007/2007‐09/2007‐09‐6789.
  • 141 London Cancer Alliance (LCA) (2015b) Oral Systemic AntiCancer Therapies (SACT) Counselling Handbook for Pharmacy and Nursing Staff. Available at: http://www.londoncanceralliance.nhs.uk/media/122917/lca‐oral‐sact‐counselling‐handbook‐amended‐march‐2016.pdf (Accessed: 7/5/2018)
  • 142 London Cancer New Drugs Group (2016) Antiemetic Guidelines for Adult Patients Receiving Chemotherapy and Radiotherapy. London: London Cancer and London Cancer Alliance.
  • 143 Macduff, C., Mackenzie, T., Hutcheon, A., et al. (2003) The effectiveness of scalp cooling in preventing alopecia for patients receiving epirubicin and docetaxel. European Journal of Cancer Care, 12 (2), 154161. Cross Ref link Pubmed link
  • 144 Marders, J. (2005) Sounding the alarm for i.v. infiltration. Nursing, 35(4), 18, 20. Cross Ref link
  • 145 MASCC: Multinational Association for Supportive Care in Cancer (2011) MASCC Antiemetic Guidelines. Available at: http://www.mascc.org/antiemetic‐guidelines (Accessed: 1/4/2018)
  • 146 Masoorli, S. (2003) Extravasation injuries associated with the use of central vascular access devices. Journal of Vascular Access Devices, 8(1), 2123. Cross Ref link
  • 147 Massey, C.S. (2004) A multicentre study to determine the efficacy and patient acceptability of the Paxman Scalp Cooler to prevent hair loss in patients receiving chemotherapy. European Journal of Oncology Nursing, 8(2), 121130. Cross Ref link Pubmed link
  • 148 Maurer, M., Handjiski, B. & Paus, R. (1997) Hair growth modulation by topical immunophilin ligands: induction of anagen, inhibition of massive catagen development, and relative protection from chemotherapy‐induced alopecia. American Journal of Pathology, 150(4), 14331441. Pubmed link
  • 149 Maxwell, M.B. (1980) Scalp tourniquets for chemotherapy‐induced alopecia. American Journal of Nursing, 80(5), 900903. Pubmed link
  • 150 Mayo, D.J. (1998) Fibrin sheath formation and chemotherapy extravasation: a case report. Supportive Care in Cancer, 6(1), 5156. Cross Ref link Pubmed link
  • 151 McCaffrey Boyle, D. & Engelking, C. (1995) Vesicant extravasation: myths and realities. Oncology Nursing Forum, 22(1), 5767. Pubmed link
  • 152 McDiarmid, M.A., Oliver, M.S., Roth, T.S., Rogers, B. & Escalante, C. (2010) Chromosome 5 and 7 abnormalities in oncology personnel handling anticancer drugs. Journal of Occupational and Environmental Medicine, 52(10), 10281034. Cross Ref link Pubmed link
  • 153 McGowan, D. (2013) Chemo induced hair loss: prevention of a distressing side effect, British Journal of Nursing, 22(10), S12. Cross Ref link Pubmed link
  • 154 Medicines and Healthcare products Regulatory Agency (MHRA) (2008) Implantable Drug Pumps for Intrathecal Therapy. All Manufacturers: MDA/2008/038. London: Medicines and Healthcare products Regulatory Agency. Available at: http://webarchive.nationalarchives.gov.uk/20141205205054/http://www.mhra.gov.uk/Publications/Safetywarnings/MedicalDeviceAlerts/CON018012 (Accessed: 7/5/2018)
  • 155 Medicines and Healthcare products Regulatory Agency (MHRA) (2014) Best Practice Guidance on Patient Information Leaflets. London: Medicines and Healthcare Regulatory Agency. Available at: www.gov.uk/government/publications/best‐practice‐guidance‐on‐patient‐information‐leaflets (Accessed: 1/4/2018)
  • 156 Middleton, J., Franks, D., Buchanan, R.B., et al. (1985) Failure of scalp hypothermia to prevent hair loss when cyclophosphamide is added to doxorubicin and vincristine. Cancer Treatment Reports, 69(4), 373375. Pubmed link
  • 157 Mols, F., Van Den Hurk, C.J., Vingerhoets, A.J. & Breed, W.P. (2009) Scalp cooling to prevent chemotherapy‐induced hair loss: practical and clinical considerations. Supportive Care in Cancer, 17(2), 181189. Cross Ref link Pubmed link
  • 158 Moureau, N.L. & Carr, P.J. (2018) Vessel Health and Preservation: a model and clinical pathway for using vascular access devices. British Journal of Nursing, 27(8), S28S35. Cross Ref link Pubmed link
  • 159 Moureau, N.L., Trick, N., Nifong, T., et al. (2012) Vessel health and preservation (Part 1): a new evidence‐based approach to vascular access selection and management. Journal of Vascular Access, 13(3), 351356. Cross Ref link Pubmed link
  • 160 Mouridsen, H.T., Langer, S.W., Buter, J., et al. (2007) Treatment of anthracycline extravasation with Savene (dexrazoxane): results from two prospective clinical multicentre studies. Annals of Oncology, 18(3), 546550. Cross Ref link Pubmed link
  • 161 Mulders, M., Vingerhoets, A. & Breed, W. (2008) The impact of cancer and chemotherapy: perceptual similarities and differences between cancer patients, nurses and physicians. European Journal of Oncology Nursing, 12(2), 97102. Cross Ref link Pubmed link
  • 162 Munstedt, K., Manthey, N., Sachsse, S. & Vahrson, H. (1997) Changes in self‐concept and body image during alopecia induced cancer chemotherapy. Supportive Care in Cancer, 5(2), 139143. Cross Ref link Pubmed link
  • 163 National Chemotherapy Advisory Group (NCAG) (2009) Chemotherapy Services in England: Ensuring Quality and Safety. London: National Chemotherapy Advisory Group.
  • 164 National Chemotherapy Board (NCB) (2016) Consent forms for SACT (Systemic Anti‐Cancer Therapy). Guidance Issued by the National Chemotherapy Board May 2016. Available at: www.cruk.org/sact_consent (Accessed: 1/4/2018)
  • 165 National Comprehensive Cancer Network (NCCN) (2018) NCCN Clinical practice guidelines in oncology. Available at: https://www.nccn.org/professionals/physician_gls/default.aspx (Accessed: 1/5/2018)
  • 166 National Institute for Occupational Safety and Health (NIOSH) (2016) NIOSH List of Antineoplastic and Other Hazardous Drugs in Healthcare Settings, 2016. DHHS (NIOSH) Publication No. 2016‐161. Available at: https://www.cdc.gov/niosh/topics/antineoplastic/pdf/hazardous‐drugs‐list_2016‐161.pdf (Accessed: 1/5/2018)
  • 167 National Patient Safety Agency (NPSA) (2008a) The National Patient Safety Agency's rapid response report. Oncology Nursing, 11(3), 387395.
  • 168 National Patient Safety Agency (NPSA) (2008b) Vinca alkaloid minibags (adult/adolescent units): NPSA/2008/RRR004. London: National Patient Safety Agency. Available at: www.nrls.npsa.nhs.uk/resources/?EntryId45=59890 (Accessed: 1/4/2018)
  • 169 National Patient Safety Agency (NPSA) (2009) Standardising Wristbands Improves Patient Safety. London: National Patient Safety Agency. Available at: http://www.nrls.npsa.nhs.uk/resources/?entryid45=59824 (Accessed: 8/5/2018)
  • 170 Naughton, C.A. (2008) Drug‐induced nephrotoxicity. American Family Physician, 78(6), 743750. Pubmed link
  • 171 Naylor, W. (2005) Extravasation of wounds; aetiology and management. In: Brighton, D. & Wood, M. (eds) The Royal Marsden Hospital Handbook of Cancer Chemotherapy: A Guide for the Multidisciplinary Team. Edinburgh: Elsevier Churchill Livingstone, pp.109112.
  • 172 Neuss, M.N., Gilmore, T.R., Belderson, K.M., et al. (2016) 2016 Updated American Society of Clinical Oncology/Oncology Nursing Society Chemotherapy Administration Safety Standards, Including Standards for Pediatric Oncology. Oncology Nursing Forum, 44(1), A1A13.
  • 173 NICE (2015) Medicines Optimisation: The Safe and Effective use of Medicines to Enable the Best Possible Outcomes. NICE Guideline [NG5] Published date: March 2015. Available at: https://www.nice.org.uk/guidance/ng5 (Accessed: 1/4/2018)
  • 174 NIHR (2017a) Clinical trials routemap toolkit. Available at: http://www.ct‐toolkit.ac.uk/routemap/ (Accessed: 1/4/2018).
  • 175 NIHR (2017b) Research design service. Available at: https://www.nihr.ac.uk/about‐us/how‐we‐are‐managed/our‐structure/research/research‐design‐service/ (Accessed: 7/5/2018)
  • 176 Nixon, S. & Schulmeister, L. (2009) Safe handling of hazardous drugs: are you protected? Clinical Journal of Oncology Nursing, 13(4), 433439. Cross Ref link Pubmed link
  • 177 NMC (2010) Standards for Medicines Management. London: Nursing & Midwifery Council.
  • 178 NMC (2015) The Code: Standards of Conduct, Performance and Ethics for Nurses and Midwives. London: Nursing & Midwifery Council.
  • 179 North of England Cancer Network (NECN) (2017) Standards for the Safe Use of Oral Anticancer Medicines. Available at: http://www.necn.nhs.uk/wp‐content/uploads/2012/11/NECN‐Oral‐Anticancer‐medicine‐Policy‐version‐1.6.pdf (Accessed: 7/5/2018)
  • 180 Oakley, C., Lennan, E., Roe, H., Craven, O., Harrold, K. & Vidall, C. (2010a) Safe practice and nursing care of patients receiving oral anticancer medicines: a position statement from UKONS. ecancermedicalscience, 4, 117.
  • 181 Oakley, C., Johnson, J. & Ream, E. (2010b) Developing an intervention for cancer patients prescribed oral chemotherapy. European Journal of Cancer Care, 19, 2128. Cross Ref link
  • 182 Oakley, C., Chambers P., Board, R., et al. (2016) Good Practice Guideline: Promoting Early Identification of Systemic Anti‐Cancer Therapies Side Effects: Two Approaches. Cancer Nursing Practice, 15(9), 1922. Cross Ref link
  • 183 Oken, M., Creech, R., Tormey, D., et al. (1982) Toxicity and response criteria of the Eastern Cooperative Oncology Group. American Journal of Clinical Oncology, 5, 649655. Cross Ref link Pubmed link
  • 184 Olsen, E.A. (2003) Current and novel methods for assessing efficacy of hair growth promoters in pattern hair loss. Journal of the American Academy of Dermatology, 48(2 supplement), 253262. Cross Ref link Pubmed link
  • 185 O'Neill, V.J. & Twelves, C.J. (2002) Oral cancer treatment: developments in chemotherapy and beyond. British Journal of Cancer, 87, 933937. Cross Ref link Pubmed link
  • 186 Ostendorf, W. (2012) Preparation for safe medication administration. In: Perry, A.G., Potter, P.A. & Elkin, M.K. (eds) Nursing Interventions & Clinical Skills, 5th edn. St Louis, MO: Elsevier, pp.486583.
  • 187 Parker, R. (1987) The effectiveness of scalp hypothermia in preventing cyclophosphamide‐induced alopecia. Oncology Nursing Forum, 14(6), 4953. Pubmed link
  • 188 Peck, H.J., Mitchell, H. & Stewart, A.L. (2000) Evaluating the efficacy of scalp cooling using the Penguin cold cap system to reduce alopecia in patients undergoing chemotherapy for breast cancer. European Journal of Oncology Nursing, 4(4), 246248. Cross Ref link Pubmed link
  • 189 Peerbooms, M., van den Hurk, C.J. & Breed, W.P. (2015) Familiarity, opinions, experiences and knowledge about scalp cooling: a Dutch survey among breast cancer patients and oncological professionals. Asia Pacific Journal of Oncology Nursing, 2(1), 3541. Cross Ref link Pubmed link
  • 190 Pérez Fidalgo, J.A., García Fabregat, L., Cervantes, A., et al., on behalf of the ESMO Guidelines Working Group (2012) Management of chemotherapy extravasation: ESMO–EONS Clinical Practice Guidelines. Annals of Oncology, 23(suppl 7), vii167vii173. Cross Ref link Pubmed link
  • 191 Pickard‐Holley, S. (1995) The symptom experience of alopecia. Seminars in Oncology Nursing, 11(4), 235238. Cross Ref link Pubmed link
  • 192 Polovich, M. (2016) Minimizing occupational exposure to antineoplastic agents. Journal of Infusion Nursing, 39(5), 307313. Cross Ref link Pubmed link
  • 193 Polovich, M. & Clark, P. (2012) Factors influencing oncology nurses’ use of hazardous drug safe‐handling precautions. Oncology Nursing Forum, 39(3), E299E309. Cross Ref link Pubmed link
  • 194 Polovich, M., Olsen, M. & LeFebvre, K. (eds) (2014) Chemotherapy and Biotherapy Guidelines and Recommendations for Practice, 4th edn. Pittsburgh, PA: Oncology Nursing Society, Chapter 9.
  • 195 Potter, P.A. (2011) Administration of nonparenteral medications. In: Perry, A.G., Potter, P.A. & Elkin, M.K. (eds) Nursing Interventions & Clinical Skills, 5th edn. St Louis, MO: Elsevier, pp.501540.
  • 196 Power, S. & Condon, C. (2008) Chemotherapy induced alopecia: a phenomenological study. Cancer Nursing Practice, 7(7), 4447. Cross Ref link
  • 197 Priestman, T.J. (1989) Cancer Chemotherapy: An Introduction, 3rd edn. London: Springer‐Verlag. Cross Ref link
  • 198 Protiere, C., Evans, K., Camerlo, J., et al. (2002) Efficacy and tolerance of a scalp‐cooling system for prevention of hair loss and the experience of breast cancer patients treated by adjuvant chemotherapy. Supportive Care in Cancer, 10(7), 529537. Cross Ref link Pubmed link
  • 199 Purohit, O.P. (1992) A 6 week chemotherapy regimen for relapsed lymphoma efficacy results and the influence of scalp cooling. Annals of Oncology, 3(5 supp), 126.
  • 200 Randall, J. & Ream, E. (2005) Hair loss with chemotherapy: at a loss over its management? European Journal of Cancer Care, 14(3), 223231. Cross Ref link Pubmed link
  • 201 RCN (2016) Standards for Infusion Therapy, 4th edn. London: Royal College of Nursing.
  • 202 RCN (2017) Using and doing research: a novice's guide. Available at: . (Accessed: 1/4/2018) https://www.rcn.org.uk/library/subject‐guides/using‐and‐doing‐research‐a‐novices‐guide
  • 203 Ridderheim, M., Bjurberg, M. & Gustavsson, A. (2003) Scalp hypothermia to prevent chemotherapy‐induced alopecia is effective and safe: a pilot study of a new digitized scalp‐cooling system used in 74 patients. Supportive Care in Cancer, 11(6), 371377. Pubmed link
  • 204 Robinson, M.H., Jones, A.C. & Durrant, K.D. (1987) Effectiveness of scalp cooling in reducing alopecia caused by epirubicin treatment of advanced breast cancer. Cancer Treatment Reports, 71(10), 913914. Pubmed link
  • 205 Rodrigues, C.C., Guilherme, C., Lobo da Costa, M., Jr. & Campos de Carvalho, E. (2012) Risk factors for vascular trauma during antineoplastic chemotherapy: contributions of the use of relative risk. Acta Paulista de Enfermagem, 25(3), 448452. Cross Ref link
  • 206 Roe, H. (2011) Anthracycline extravasations: prevention and management. British Journal of Nursing, 20(17), S18S22. Cross Ref link Pubmed link
  • 207 Roe, H. (2014) Scalp cooling: management option for chemotherapy induced alopecia. British Journal of Nursing, 23(16), S4S11. Cross Ref link Pubmed link
  • 208 Roe, H. & Lennan, E. (2014) Role of nurses in the assessment and mangement of chemotherapy‐related side effects in cancer patients. Nursing: Research and Reviews, 4, 103115.
  • 209 Ron, I.G., Kalmus, Y., Kalmus, Z., et al. (1997) Scalp cooling in the prevention of alopecia in patients receiving depilating chemotherapy. Supportive Care in Cancer, 5(2), 136138. Cross Ref link Pubmed link
  • 210 Rosenblatt, L. (2006) Being the monster: women's narratives of body and self after treatment for breast cancer. Medical Humanities, 32(1), 5356. Cross Ref link Pubmed link
  • 211 Rosman, S. (2004) Cancer and stigma: experience of patients with chemotherapy‐induced alopecia. Patient Education and Counseling, 52(3), 333339. Cross Ref link Pubmed link
  • 212 Roth, D. (2003) Extravasation injuries of peripheral veins: a basis for litigation. Journal of Vascular Access Devices, 8(1), 1320. Cross Ref link
  • 213 Ruddy, K., Mayer, E. & Partridge, A. (2009) Patient adherence and persistence with oral anticancer treatment. CA: Cancer Journal for Clinicians, 59, 5666. Cross Ref link
  • 214 Rudolph, R. & Larson, D.L. (1987) Etiology and treatment of chemotherapeutic agent extravasation injuries: a review. Journal of Clinical Oncology, 5(7), 11161126. Cross Ref link Pubmed link
  • 215 Rugo, H., Serrurier, K.M., Melisko, M., et al. (2012) Use of the DigniCap System to prevent hair loss in women receiving chemotherapy (CTX) for Stage 1 breast cancer (BC). Cancer Research, 72(24 Suppl), 212. Cross Ref link
  • 216 Sansivero, G. & Barton‐Burke, M. (2001) Chemotherapy administration: general principles for vascular access. In: Barton‐Burke, M., Wilkes, G.M. & Ingwersen, K. (eds) Cancer Chemotherapy: A Nursing Process Approach, 3rd edn. Sudbury, MA: Jones and Bartlett, pp.645670.
  • 217 Satterwhite, B. & Zimm, S. (1984) The use of scalp hypothermia in the prevention of doxorubicin‐induced hair loss. Cancer, 54(1), 3437. Cross Ref link Pubmed link
  • 218 Sauerland, C., Engelking, C., Wickham, R. & Corbi, D. (2006) Vesicant extravasation part I: mechanisms, pathogenesis, and nursing care to reduce risk. Oncology Nursing Forum, 33(6), 11341142. Cross Ref link Pubmed link
  • 219 Scales, K. (2005) Vascular access: a guide to peripheral venous cannulation. Nursing Standard, 19(49), 4852. Cross Ref link Pubmed link
  • 220 Scaramuzzo, L. (2017) Patient education. In: Newton, S., Hickey, M., & Brant, J.M. (eds) Mosby's Oncology Nursing Advisor: A Comprehensive Guide to Clinical Practice. St Louis: Elsevier, pp.436442.
  • 221 Schaffrin‐Nabe, D. Schmitz, I., Josten‐Nabe, A., von Hehn, U. & Voigtmann, R. (2015) The influence of various parameters on the success of sensor‐controlled scalp cooling in preventing chemotherapy‐induced alopecia. Oncology Research and Treatment, 38(10), 489495. Cross Ref link Pubmed link
  • 222 Schrijvers, D.L. (2003) Extravasation: a dreaded complication of chemotherapy. Annals of Oncology, 14(Suppl 3), iii26iii30. Pubmed link
  • 223 Schulmeister, L. (1998) A complication of vascular access device insertion. A case study and review of subsequent legal action. Journal of Intravenous Nursing, 21(4), 197202. Pubmed link
  • 224 Schulmeister, L. (2009) Antineoplastic therapy. In: Infusion Therapy and Transfusion Medicine. Basel: S. Karger AG, pp.366367.
  • 225 Schwartz, A.L. (2007) Understanding and treating cancer‐related fatigue. Oncology, 21(11 suppl), 3034. Pubmed link
  • 226 Scottish Government (2012) [Revised] Guidance for the safe delivery of systemic anti‐cancer therapy, CEL 30. Available at: http://www.sehd.scot.nhs.uk/mels/CEL2012_30.pdf (Accessed: 8/5/2018)
  • 227 Scurr, M. (2005) Combination chemotherapy and chemotherapy principles. In: Brighton D. & Wood M. (eds) The Royal Marsden Hospital Handbook of Cancer Chemotherapy: A Guide for the Multidisciplinary Team. Edinburgh: Elsevier Churchill Livingstone, pp.1729.
  • 228 Serrurier, K.M., Melisko, M.E., Glencer, A., Esserman, L.J. & Rugo, H.S. (2012) Efficacy and safety of scalp cooling treatment for alopecia prevention in women receiving chemotherapy (CTX) for breast cancer (BC). Cancer Research Meeting Abstracts, 72(24a), 725726. Available at: http://cancerres.aacrjournals.org/content/72/24_Supplement/P2‐12‐12 (Accessed: 8/5/2018)
  • 229 Seto, T., Ushijima, S., Yamamoto, H., et al. (2006) Intrapleural hypotonic cisplatin treatment for malignant pleural effusion in 80 patients with non‐small‐cell lung cancer: a multi‐institutional phase II trial. British Journal of Cancer, 95(6), 717721. Cross Ref link Pubmed link
  • 230 Sewell, G., Summerhayes, M. & Stanley, A. (2002) Administration of chemotherapy. In: Allwood, M., Stanley, A. & Wright, P. (eds) The Cytotoxics Handbook, 4th edn. Oxford: Radcliffe Medical Press, pp.85115.
  • 231 Shah, N., Groom, N., Jackson, S., et al. (2000) A pilot study to assess the feasibility of prior scalp cooling with palliative whole brain radiotherapy. British Journal of Radiology, 73(869), 514516. Cross Ref link Pubmed link
  • 232 Shapiro, J. & Price, V.H. (1998) Hair regrowth. Therapeutic agents. Dermatologic Clinics, 16(2), 341356. Cross Ref link Pubmed link
  • 233 Sharma, S. & Saltz, L.B. (2000) Oral chemotherapeutic agents for colorectal cancer. Oncologist, 5(2), 99107. Cross Ref link Pubmed link
  • 234 Shin, H., Jo, S.J., Kim, D.H., Kwon, O. & Myung, S.K. (2015) Efficacy of interventions for prevention of chemotherapy‐induced alopecia: a systematic review and meta‐analysis. International Journal of Cancer, 136(5), E442E454. Cross Ref link Pubmed link
  • 235 Shuey, K. & Payne, Y. (2005). Administration considerations. In: Polovich, M., Olsen, M. & LeFebvre, K. (eds) Chemotherapy and Biotherapy Guidelines and Recommendations for Practice. Pittsburgh, PA: Oncology Nursing Society, p.125.
  • 236 Skeel, R. (2016) Biologic and pharmacologic basis of cancer chemotherapy. In: Khleif, S., Rixe, O. & Skeel, R. (eds) Skeel's Handbook of Cancer Therapy, 9th edn. Philadelphia, AP: Wolters Kluwer, p.2.
  • 237 Spaëth, D., Luporsi, E., Coudert, B., et al. (2008) Efficacy and safety of cooling helmets for the prevention of chemotherapy induced alopecia: a prospective study of 911 patients. Paper presented at ASCO, Chicago, May 30–June 3.
  • 238 Sredni, B., Xu, R.H., Albeck, M., et al. (1996) The protective role of the immunomodulator AS101 against chemotherapy‐induced alopecia studies on human and animal models. International Journal of Cancer, 65(1), 97103. Cross Ref link Pubmed link
  • 239 Stanley, A. (2002) Managing complications of chemotherapy administration. In: Allwood, M., Stanley, A. & Wright, P. (eds) The Cytotoxics Handbook, 4th edn. Oxford: Radcliffe Medical Press, pp.119192.
  • 240 Symonds, R.P., McCormick, C.V. & Maxted, K.J. (1986) Adriamycin alopecia prevented by cold air scalp cooling. American Journal of Clinical Oncology, 9(5), 454457. Cross Ref link Pubmed link
  • 241 Szetela, A.B. & Gibson, D.E. (2007) How the new oral antineoplastics affect nursing practice: capecitabine serves to illustrate. American Journal of Nursing, 107(12), 4048. Cross Ref link Pubmed link
  • 242 Tierney, A.J. (1987) Preventing chemotherapy‐induced alopecia in cancer patients: is scalp cooling worthwhile? Journal of Advanced Nursing, 12(3), 303310. Cross Ref link Pubmed link
  • 243 Tierney, A.J. (1989) A Study to Inform Nursing Support of Patients Coping with Chemotherapy for Breast Cancer. Edinburgh: Department of Nursing Studies, University of Edinburgh.
  • 244 Toft, B. (2001) External Inquiry into the adverse incident that occurred at Queen's Medical Centre, Nottingham, 4th January 2001. London: Department of Health. Available at: http://webarchive.nationalarchives.gov.uk/20120524040348/http://www.dh.gov.uk/prod_consum_dh/groups/dh_digitalassets/@dh/@en/documents/digitalasset/dh_4082098.pdf (Accessed: 7/5/2018)
  • 245 Tollenaar, R.A., Liefers, G.J., Repelaer van Driel, O.J. & van de Velde, C.J. (1994) Scalp cooling has no place in the prevention of alopecia in adjuvant chemotherapy for breast cancer. European Journal of Cancer, 30A(10), 14481453. Cross Ref link Pubmed link
  • 246 Tortora, G.J. & Derrickson, B. (2009) Principles of Anatomy and Physiology, 12th edn. Hoboken, NJ: John Wiley.
  • 247 Toumeh, A. & Skeel, R. (2016) Classification, use and toxicity of clinically useful chemotherapy and molecular targeted therapy. In: Khleif, S., Rixe, O. & Skeel, R. (eds) Skeel's Handbook of Cancer Therapy, 9th edn. Philadelphia, PA: Wolters Kluwer, p.667.
  • 248 UK Oncology Nursing Society (UKONS) (2018) Systemic Anti‐cancer Therapy (SACT) Competency Passport. Oral, Intravenous, Subcutaneous and Intramuscular SACT Administration for Adult Patients. Available at: www.ukons.org/downloads/home.
  • 249 Ulutin, H.C., Guden, M., Dede, M. & Pak, Y. (2000) Comparison of granulocyte‐colony, stimulating factor and granulocyte macrophage‐colony stimulating factor in the treatment of chemotherapy extravasation ulcers. European Journal of Gynaecological Oncology, 21(6), 613615. Pubmed link
  • 250 Uno, H. & Kurata, S. (1993) Chemical agents and peptides affect hair growth. Journal of Investigative Dermatology, 101(1 Suppl), 143S147S. Cross Ref link Pubmed link
  • 251 Valanis, B., Vollmer, W.M. & Steele, P. (1999) Occupational exposure to antineoplastic agents: self‐reported miscarriages and stillbirths among nurses and pharmacists. Journal of Occupational and Environmental Medicine, 41(8), 632638. Cross Ref link Pubmed link
  • 252 Van den Hurk, C.J.G., Mols, F., Vingerhoets, J.J.M. & Breed, W.P.M. (2010) Impact of alopecia and scalp cooling on the well being of breast cancer patients. Psychooncology, 19(7), 701709. Cross Ref link Pubmed link
  • 253 Van den Hurk, C.J.G., Breed, W.P.M. & Nortier, J.W.R. (2012a) Short post infusion scalp cooling time in the prevention of docetaxel induced alopecia. Supportive Care in Cancer, 20(12), 32553260. Cross Ref link Pubmed link
  • 254 Van den Hurk, C.J., Peerbooms, M., van de Poll‐Franse, L.V., Nortier, J.W., Coebergh, J.W. & Breed, W.P. (2012b) Scalp cooling for hair preservation and associated characteristics in 1411 chemotherapy patients – results of the Dutch Scalp Cooling Registry. Acta Oncologica, 51(4), 497504. Cross Ref link Pubmed link
  • 255 Van den Hurk, C.J.G., van den Akker‐van Marle, M.E., Breed, W.P., van de Poll‐Franse, L.V., Nortier, J.W. & Coebergh, J.W. (2013a) Impact of scalp cooling on chemotherapy induced alopecia: wig use and hair growth of patients with cancer. European Journal of Oncology Nursing, 17(5), 536540. Cross Ref link Pubmed link
  • 256 Van den Hurk, C.J.G., van de Poll‐Franse, L.V., Breed, W.P., Coebergh, J.W. & Nortier, J.W. (2013b) Scalp cooling to prevent alopecia after chemotherapy can be considered safe in patients with breast cancer. Breast, 22(5), 10011004. Cross Ref link Pubmed link
  • 257 Van den Hurk, C.J., van den Akker‐van Marle, M.E., Breed, W.P., van de Poll‐Franse, L.V., Nortier, J.W. & Coebergh, J.W. (2014) Cost‐effectiveness analysis of scalp cooling to reduce chemotherapy‐induced alopecia. Acta Oncologica, 53, 8087. Cross Ref link Pubmed link
  • 258 Van den Hurk, C., de Beer, F., Dries, W., et al. (2015) No prevention of radiotherapy‐induced alopecia by scalp cooling. Radiotherapy and Oncology, 117(1), 193194. Cross Ref link Pubmed link
  • 259 Van der Molen, B. (2005) Patient information and education. In: Brighton, D. & Wood, M. (eds) The Royal Marsden Hospital Handbook of Cancer Chemotherapy: A Guide for the Multidisciplinary Team. Edinburgh: Elsevier Churchill Livingstone, pp.4959.
  • 260 Vidall, C., Roe, H., Dougherty, L. & Harrold, K. (2013) Dexrazoxane: a management option for anthracycline extravasations. British Journal of Nursing, 22(17), S6S12. Cross Ref link Pubmed link
  • 261 Viele, C.S. (2007) Managing oral chemotherapy: the healthcare practitioner's role. American Journal of Health‐System Pharmacy, 64(9 Suppl 5), S25S32.
  • 262 Vioral, A. (2018) In: Yarbro, C.H., Wujcik, D., Holmes Gobel, B. (eds) Cancer Nursing. Principles and Practice, 8th edn. Burlington, MA: Jones & Bartlett Learning, Chapter 44.
  • 263 Vleut, R.E., van Poppel, J.E., Dercksen, M.W., Peerbooms, M., Houterman, S. & Breed, W.P. (2013) Hair mass index obtained by cross‐section trichometry: an objective and clinically useful parameter to quantify hair in chemotherapy‐induced alopecia. Supportive Care in Cancer, 21(7), 18071814. Cross Ref link Pubmed link
  • 264 Washburn, D.J. (2007) Intravesical antineoplastic therapy following transurethral resection of bladder tumors: nursing implications from the operating room to discharge. Clinical Journal of Oncology Nursing, 11(4), 553559. Cross Ref link Pubmed link
  • 265 Weinstein, S. & Hagle, M.E. (2014) Plumer's Principles and Practice of Intravenous Therapy, 9th edn. Philadelphia, PA: Lippincott Williams and Wilkins, Chapter 19.
  • 266 Wheelock, J.B., Myers, M.B., Krebs, H.B. & Goplerud, D.R. (1984) Ineffectiveness of scalp hypothermia in the prevention of alopecia in patients treated with doxorubicin and cisplatin combinations. Cancer Treatment Reports, 68(11), 13871388. Pubmed link
  • 267 Wickham, R., Engelking, C., Sauerland, C. & Corbi, D. (2006) Vesicant extravasation part II: Evidence‐based management and continuing controversies. Oncology Nursing Forum, 33(6), 11431150. Cross Ref link Pubmed link
  • 268 Wilkes, G.M. (2018) In: Yarbro, C.H., Wujcik, D., Holmes Gobel, B. (eds) Cancer Nursing. Principles and Practice, 8th edn. Burlington, MA: Jones & Bartlett Learning, Chapter 15.
  • 269 Williams, J., Wood, C. & Cunningham‐Warburton, P. (1999) A narrative study of chemotherapy‐induced alopecia. Oncology Nursing Forum, 26(9), 14631468. Pubmed link
  • 270 Williamson, S. (2008) Management of oral anti‐cancer therapies. Pharmaceutical Journal, 281, 399402.
  • 271 Wilson, C. (1994) The ice cap that could help save your hair. Daily Mail, September 20th, pp.3637.
  • 272 Winkeljohn, D.L. (2007) Oral chemotherapy medications: the need for a nurse's touch. Clinical Journal of Oncology Nursing, 11(6), 793796. Cross Ref link Pubmed link
  • 273 Witman, G., Cadman, E. & Chen, M. (1981) Misuse of scalp hypothermia. Cancer Treatment Reports, 65(5–6), 507508. Pubmed link
  • 274 Workman, B. (1999) Safe injection techniques. Nursing Standard, 13(39), 4753. Cross Ref link Pubmed link
  • 275 Yang, X. & Thai, K.E. (2015) Treatment of permanent chemotherapy‐induced alopecia with low dose oral minoxidil. The Australasian Journal of Dermatology, 57, . Cross Ref link Pubmed link
  • 276 Yarbro, C.H., Wujcik, D., Holmes Gobel, B. (eds) (2018) Cancer Nursing. Principles and Practice, 8th edn. Burlington, MA: Jones & Bartlett Learning.
  • 277 Yoshida, J., Kosaka, H., Tomika, K. & Kumagai, S. (2006) Genotoxic risks to nurses from contamination of the work environment with antineoplastic drugs in Japan. Journal of Occupational Health, 48, 517522. Cross Ref link Pubmed link
  • 278 Young, A. (2013) Chemotherapy induced alopecia: a cool to action. British Journal of Nursing, 22(11), 608. Cross Ref link Pubmed link
  • 279 Young, A. & Arif, A. (2016) The use of scalp cooling for chemotherapy induced hair loss. British Journal of Nursing, 25(10), S22S27. Cross Ref link Pubmed link